Misoprostol interactions
Full monograph for MisoprostolCheck it against another medicine
Medicines
318 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Oxytocin | Major | Synergy | Prostaglandins, especially those of the E type such as misoprostol, may potentiate the uterine response to oxytocin and increase the risk of uterine… | 4 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide | Moderate | Absorption · Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid…2 documented mechanisms | 4 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide + Simethicone | Moderate | Absorption · Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid…2 documented mechanisms | 4 sources — open the full entry |
| Aluminium Oxide + Magnesium Trisilicate | Moderate | Absorption · Synergy | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Calcium acetate + Magnesium carbonate | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Magaldrate | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Magaldrate + Simethicone | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Magnesium Hydroxide | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Magnesium Hydroxide + Liquid Paraffin | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Magnesium Oxide | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Sodium Picosulfate + Magnesium Oxide + Citric Acid | Moderate | Others | Magnesium-containing antacids can exacerbate misoprostol-induced diarrhea. Additionally, antacids in general can reduce the bioavailability of misoprostol acid… | 2 sources — open the full entry |
| Calcium Carbonate | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C + Vitamin D3 | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 + Multiminerals | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
| Naproxen Sodium | Minor | Synergy | single case report suggests that concomitant use of naproxen and misoprostol may increase the risk of neurological side effects. Until more data are available… | 1 sources — open the full entry |
| Naproxen Sodium + Esomeprazole Magnesium | Minor | Synergy | single case report suggests that concomitant use of naproxen and misoprostol may increase the risk of neurological side effects. Until more data are available… | 1 sources — open the full entry |
| Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction…2 documented mechanisms | 2 sources — open the full entry |
| Sodium Bicarbonate | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
| Sodium Bicarbonate + Citric Acid + Sodium Carbonate | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
| Sodium Bicarbonate [Ear Preparations] | Minor | Absorption | Concomitant administration of antacids can reduce the bioavailability of misoprostol acid, the active metabolite of misoprostol. The mechanism of interaction… | 2 sources — open the full entry |
Conditions
Conditions in which Misoprostol needs care, as documented in this source.
Cardiovascular Diseases
ModerateCaution should be employed when administering misoprostol to patients with preexisting cardiovascular disease.
1 source
- "Product Information. Cytotec (misoprostol)." Searle (2001):
Diarrhea
ModerateDiarrhea may occur in up to 40% of patients receiving misoprostol. Misoprostol should be administered cautiously in patients with underlying conditions such as inflammatory bowel disease and dehydration. Careful monitoring during therapy is recommended.
2 sources
- Wildeman RA "Focus on misoprostol: review of worldwide safety data." Clin Invest Med 10 (1987): 243-5
- "Product Information. Cytotec (misoprostol)." Searle (2001):